With the increasing house prices must make Heartland reverse mortgage look more compelling for both borrowers and lender , surely should reflect in share price .
Printable View
With the increasing house prices must make Heartland reverse mortgage look more compelling for both borrowers and lender , surely should reflect in share price .
Financials do have a very high Covid beta as they are very sensitive to the economic effects of Covid on their customers and the opposite, to the recovery prospects that vaccines give hope for so its is very surprising to note that while many US, European and Australian financials have rebounded strongly on the hopes of the Pfizer vaccine and yesterday's Modera vaccine with an even higher efficacy at 94.5% HGH has been stuck pretty much in the doldrums.
For many years now I have compared the forward metrics to HGH's peers in Australia and found a very close correlation. Its not often that HGH's forward PE is more or less than 2 different to the average of its peers so imagine my surprise when I noted yesterday that based on HGH's official forecast at the midpoint of $84m = 14.4 cps HGH are currently on a forward FY21 PE of just 9.4 !
This compares with peers as follows, (all figures are average analyst forecasts off market screener)
ANZ 13.3
WBC 13.4
NAB 15.8
BEN 14.3
BOQ 14.4
CBA 18.2
Peer Group Average 14.9
Leaving aside the outlier of this group CBA which for reasons unknown is also trading at about twice NTA this still gives an average forward PE for the Australian banks of 14.25.
In my experience HGH's normal trading range on a forward PE basis is 11 - 17.5 with the mid point also being 14.25.
I have never seen HGH trade at a discount of this size to its peer group, nothing remotely like it so this presents as a real overlooked recovery story.
I think as 2021 unfolds and the recovery story and vaccinations get rolled out HGH has excellent prospects to recover towards the mid point of its historical PE range which is where the Australian banks already are.
14.25 x officially forecast of 14.4 cps = Target Price of $2.05. I think HGH has excellent prospects to make a strong recovery in 2021. I already have a sizeable position and added some more this morning.
I note the RBNZ dividend restrictions still apply so I am only expecting 5 cps (6.94 cps gross) in fully imputed dividends in the year ahead which gives a gross yield of 6.94 / 137 = 5.1% but I am expecting that to approximately double for FY22 and beyond and on a look through Covid recovery basis HGH could give a 10% Gross Yield in FY22
For someone good at maths.?
Medium price for an Auckland house is approx $1 mil.
70 year old borrows using a HGH REL a thousand dollars a week to spend.His house is worth currently $1mil.
Lives 10 years .So would owe $520,000 plus interest at 3% just under $70,000.
I would guess his house goes up $2,000 a week.So house is worth over $2mil when he dies.
His estate would be $2mil less what he owes HGH $590,000 ie Leaving $1,410,000.
Certainly beats selling the house for $1mil and buying a $1mil unit at The Sands.
Plenty of people seem to think so Percy with the massive growth in reverse equity loans !
The numbers on page 23 tell a real story about what the size of this part of their business has grown too and I expect very strong growth in the years ahead. http://nzx-prod-s7fsd7f98s.s3-websit...278/333910.pdf
From a financial viewpoint retirement living is a terrible investment but from a lifestyle perspective many people think its the best thing they ever did ! I know my Mum has enjoyed a fabulous 11 years at her retirement village and been so incredibly happy and well supported there...I couldn't care less that I will inherit less, her happiness in her sunset years is all that matters to me.
Re HGH v the peer group Beagle uses (Aussie banks)
I've always said Price/NTA is a better multiple to use than PE ratios for banks. Allows for different leverage and things. (Note: in reality prefer using Book Value instead of NTA but can't be bothered looking them all up for this exercise)
So I've compared the HGH peer group based on Price/NTA multiples (ex Direct Broking) - they are shown on the chart below.
I've dome this exercise a few times over the years and found that the average has always been around 1.3 plus or minus a bit and that HGH except for those totally irrational exuberant times the HGH share price has been over 2 bucks and was heading that way has been close to the average of its peers.
I don't see HGH going to 2 bucks soon - unless HGH con the market into thinking they really are a fintech stock
one could say if you take CBA out HGH are one of more highly valued stocks in the peer group
There are a number of ways to value a stock. PE as per Beagle, Price/NTA as per W69, reading tea leaves as FB seems to use. Personally I prefer to look at the divends and establish a price that will give me a return, purely on dividends, of 5% after tax. On that basis I have a fair value for HGH of $1.67. So somewhat less than Beagle's value but still ahead of W69.
Yeah I worked that out too mate but didn't share it because I knew you would, you're as predictable as a Swiss watch sometimes :p Unsurprisingly I prefer my methodology because it takes into account the return on capital, (net assets) employed in the business. Its all very well having assets but if your net interest margin is half that of HGH you need twice as many to get the same return ! Remind me again, who sold at $2.14 when someone else was calling for $2.50 and what was the top price ? :p
I recall it was you ...Beagle ....who sold at $2.15 knowing it was never going to go $2.50. Very canny of you.
And by the way Price/BV implicitly has a ROE component along with growth, required returns and payout ratios.
Do you think the high payout rate (dividend) is a drag on long term share price growth?
Yeah somewhat but those dividends are awesome.
HGH is currently priced like an abandoned baby ;)
Fantastic posts winner and Beagle, very good reading and data to back it up.
re: CBA as an outlier in both your postings
Based on the capital ratios as I detailed on here on this thread: https://www.sharetrader.co.nz/showth...l=1#post845234
Here is a good read around BAC and Buffet's position on it: https://www.fool.com/investing/2020/...ment-in-b.aspx once you've read that article, I think its safe to ascertain that CBA is the Bank of America with regards to Australia/NZ.
One thing that would certainly re-rate HGH's Shareprice higher is improving these capital ratios.